Streamlining Validation for Global Gene Therapy CDMO

This case study details the validation processes employed by a global contract development and manufacturing organization (CDMO) in the life sciences sector. The CDMO faced significant challenges, including varied validation processes across nine international facilities, leading to inefficiencies and a lack of visibility into compliance status. The solution involved standardizing validation documentation through Res_Q, which established a unified source of truth and provided leadership with full organizational visibility into validation status. The scalable platform supported the CDMO's growth strategy, allowing for new projects and facilities to onboard without increasing headcount. As a result, compliance was accelerated, with test execution speeds improving by 20-40% and approval cycles reduced from weeks to days. The CDMO also achieved early FDA approvals for three critical SaaS systems, projecting annual labor savings of over $130K, equivalent to 2,070 hours of work. Future collaborations are planned to further enhance operational efficiency.